We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GQG:ASXGQG Partners, Inc. Shs Chess Depository Interests Repr 1 Sh Analysis

Data as of 2026-06-03 - not real-time

A$1.40

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

GQG Partners is trading at AU$1.395, well below its 20‑day, 50‑day and 200‑day moving averages of 1.54, 1.63 and 1.67 respectively, signalling a bearish technical backdrop. The RSI of 25.5 indicates oversold conditions, while a bearish MACD histogram reinforces short‑term downside pressure. Despite the price weakness, the stock boasts a PE of 6.34 versus an industry average of 16.6, a dividend yield of 14.98% and a payout ratio under 80%, suggesting the dividend remains sustainable given robust operating cash flow and a free cash flow conversion of roughly 62%. The DCF model places fair value at AU$1.91, implying a potential upside of about 36%, and the Fear & Greed Index’s “Extreme Greed” reading reflects market appetite for high‑yield assets.
The fundamentals are solid: revenue grew 2% year‑over‑year, margins are exceptionally high (gross 82%, operating 78%, profit 57%), and the balance sheet is strong with cash exceeding debt. Low beta (~0.18) and a 30‑day volatility of 31% point to modest market correlation but elevated price swings. With a max drawdown near 42% historically, downside risk exists, yet the combination of deep valuation discount, attractive dividend and low market sensitivity makes GQG a compelling buy for income‑focused investors who can tolerate short‑term volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Oversold RSI suggests possible short‑term bounce
  • Price below all major moving averages indicates bearish trend
  • High dividend yield provides income cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to DCF fair value and peers
  • Sustainable dividend with strong cash flow generation
  • Low beta reduces market‑wide exposure

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Consistently high profit margins and cash conversion
  • Attractive yield in a low‑interest‑rate environment
  • Limited regulatory and geographic headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth2.00%
Profit Margin57.32%
P/E Ratio6.3
ROE107.64%
ROA81.28%
Debt/Equity6.04
P/B Ratio6.6
Op. Cash FlowA$483.1M
Free Cash FlowA$388.3M
Industry P/E16.6

Technical Analysis

TrendBearish
RSI25.6
SupportA$1.39
ResistanceA$1.71
MA 20A$1.54
MA 50A$1.63
MA 200A$1.67
MACDBearish
VolumeStable
Fear & Greed Index92.82

Valuation

Fair ValueA$1.91
Target PriceA$1.90
Upside/Downside35.97%
GradeUndervalued
TypeValue
Dividend Yield14.98%

Risk Assessment

Beta0.18
Volatility31.02%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.